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The hydrolytic products of sphingomyelin (SM) triggered by
sphingomyelinases (SMase) are important molecules that regulate
cell proliferation, differentiation and programmed cell death
(Kolesnik, 1991; Hannun and Linnardi, 1993). Three types of
SMase have been identified so far. The first two, termed acid and
neutral SMase respectively, have been found in many tissues and
are considered as common cellular enzymes (Chatterjee, 1994;
Spence, 1994). The third enzyme, alkaline SMase, has been
located specifically to the intestinal tract, where high levels are
found in the small intestine and lower in the colon with a gradual
decline towards rectum (Nilsson, 1969; Duan et al, 1995a, 1995b).
This enzyme may play an important role in the digestion of dietary
SM (Nyberg et al, 1997) and provide the intestinal mucosa with
ceramide, a key molecule to induce apoptosis (Obeid et al, 1993).
Recent animal studies indicate that the digestion and hydrolysis
of SM may have an inhibitory effect on neoplastic transformation
in the colorectal mucosa. Human colonic carcinomas, as well as
the colonic mucosa of rats treated with colonic carcinogens, are
associated with an accumulation of SM (Dudeja et al, 1986;
Merchant et al, 1995). In normal mice, dietary supplement of SM
has been shown to reduce the number of aberrant colonic crypt
foci (considered to be early biomarkers of dysplastic change in the
epithelium) and mice given 1,2-dimethyl-hydrazine, a colonic
carcinogen, together with SM, showed an increase in the propor-
tion of adenomas versus adenocarcinomas, indicating a possible
chemopreventive role (Dillehay et al, 1994; Schmelz et al, 1996).
We recently found that human colorectal carcinomas had a 75%
reduction of alkaline SMase activity compared to the normal
adjacent mucosa (Hertervig et al, 1997).
Familial adenomatous polyposis (FAP) is an autosomal domi-
nant disease that affects 1 in 7000 individuals. Patients with FAP
typically develop hundreds to thousands of colorectal adenoma-
tous polyps, and the large numbers of polyps virtually guarantee
that some of the polyps in each affected individual will progress
to invasive carcinoma. The critical underlying mechanism for
tumour initation is the germline mutation of the adenomatous
polyposis (APC) gene; however, a progress to invasive carcinoma
requires a series of other somatic mutations including the p53
gene, the k-ras gene and the ‘deleted in colorectal cancer’ gene
(DCC) (Kinzler, 1994).
In order to find out whether the decrease in alkaline SMase
activity is an early phenomenon in the colorectal tumorigenesis,
occurring before malignant transformation, we extended our
previous study by measuring alkaline SMase activity in colorectal
mucosa of FAP patients as well as in sporadic adenomas. A sharp
and specific decrease of alkaline SMase activity in both adenomas
and surrounding mucosa of FAP patients has been demonstrated,
which indicates that this enzyme may be an important factor in the
unrestrained cell proliferation and malignant transformation in the
colorectal mucosa.
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Summary The hydrolysis of sphingomyelin generates key molecules regulating cell growth and inducing apoptosis. Data from animal cancer
models support an inhibitory role for this pathway in the malignant transformation of the colonic mucosa. In the intestinal tract, a
sphingomyelinase with an optimum alkaline pH has been identified. We recently found that the activity of alkaline sphingomyelinase is
significantly decreased in colorectal adenocarcinomas, indicating a potential anticarcinogenic role of this enzyme. To further examine whether
the reduction of sphingomyelinase is present already in the premalignant state of neoplastic transformation, we measured sphingomyelinase
activities in patients with familial adenomatous polyposis (FAP) and in sporadic colorectal tubulovillous adenomas. Tissue samples were
taken from adenomas and surrounding macroscopically normal mucosa from 11 FAP patients operated with ileorectal anastomosis, from
three FAP patients with intact colon, from 13 patients with sporadic colorectal adenomas and from 12 controls. Activities of acid, neutral and
alkaline sphingomyelinase were measured together with alkaline phosphatase. In FAP adenoma tissue, alkaline sphingomyelinase activity
was reduced by 90% compared to controls (P < 0.0001), acid sphingomyelinase by 66% (P < 0.01) and neutral sphingomyelinase by 54%
(P < 0.05). Similar reductions were found in the surrounding mucosa. In sporadic adenoma tissue, only alkaline sphingomyelinase was
reduced significantly, by 57% (P < 0.05). Alkaline phosphatase was not changed in FAP adenomas, but decreased in the sporadic adenomas.
We conclude that the markedly reduced levels of alkaline sphingomyelinase activities in FAP adenomas and in the surrounding mucosa may
be a pathogenic factor that can lead to unrestrained cell proliferation and neoplastic transformation.
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Materials
Biopsies were obtained from rectal adenomas in 11 FAP patients
operated with colectomy and ileorectal anastomosis (mean age
49.5 years, range 30–73 years; five males, six females). Six of the
patients also had biopsies taken from macroscopically normal
surrounding mucosa. In addition, rectal biopsies were obtained
from adenomas and the surrounding mucosa in three other FAP
patients with intact colon (two males, 23 and 27 years; one female,
22 years).
Sporadic polyps were obtained from the rectosigmoid colon by
colonoscopy and polypectomy in 15 patients. Two of the polyps
that had carcinoma on histopathological examination were
excluded. The remaining 13 polyps were benign colorectal
tubulovillous adenomas with varying dysplasia (mean age 72
years, range 49–82 years; seven males, six females). The
adenomas are characterized in Table 1. Biopsies were also taken
from macroscopically normal adjacent mucosa. Control rectal
biopsies were obtained from 12 patients referred to colonoscopy
for abdominal symptoms, but with a macroscopically normal
colonoscopy and without microscopical pathological findings
(mean age 45.7 years, range 22–83 years; four males, eight
females). Permission to obtain biopsies were obtained by the local
ethical committees in Lund and Stockholm.
Purified milk SM (purity > 98%) and choline labelled 14C-SM
(56 mCi mg–1) were kindly provided by Lena Nyberg, Swedish
Dairy Association and by Peter Ström, Astra Draco, Lund (Stoffel,
1975; Nyberg et al, 1996). Taurocholate (TC), taurodeoxycholate
(TDC), glycocholate (GC), glycochenodeoxycholate (GCDC),
benzamidine and phenylmethylsulphonyl fluoride (PMSF) were
purchased from Sigma Co (St Louis, MO, USA).
Sample preparation
The biopsy samples were homogenized in 0.5 ml 0.25 M sucrose
buffer containing 5 mM magnesium chloride (MgCl2), 0.15 M
potassium chloride (KCl), 50 mM KH2PO4, 1 mM PMSF, 1 mM
benzamidine and 10 mM TC, pH 7.4, followed by sonication for
10 s. After centrifugation at 10 000 rpm at 4°C for 15 min, the
supernatant was saved for determination of SMase activity,
alkaline phosphatase activity and protein content.
Sphingomyelinase activity assay
The activity of alkaline SMase was determined according to Duan
et al (1995a, 1995b) which is a modification of an original method
for neutral SMase (Gatt, 1975). Briefly, samples were added in 375
ml Tris–EDTA buffer pH 9.0 to a final volume of 0.4 ml, containing
50 mM Tris, 0.15 M sodium chloride (NaCl), 2 mM EDTA and 3 mM
bile salt mixture with a molar ratio TC:TDC:GC:GCDC being
3:2:1.8:1. Such a bile salt mixture had previously shown to have the
maximum stimulatory effect on alkaline SMase (Duan 1995a,
Nyberg et al, 1996). The supplement of EDTA in the buffer served
to inhibit the neutral SMase activity which is magnesium ion-
dependent with a pH optimum at 7.5 (Chatterjee, 1994). 14C-SM
dissolved in ethanol was suspended in 0.9% NaCl containing 3 mM
bile salt mixture. The reaction was started by adding 100 ml 14C-SM
(40 000 dpm) suspension, incubated at 37°C for 30 min, and termi-
nated by adding 2 ml chloroform:methanol (2:1). After phase
partition and centrifugation, an aliquot of the upper phase
containing the cleaved phosphocholine was taken and the radio-
activity was counted by liquid scintillation. The activity was calcu-
lated and normalized as nmol h–1 mg–1 sample protein.
The activities of neutral and acid SMases were measured by the
same procedure described above except small modifications of the
buffers. Neutral SMase was assayed in buffer containing 50 mM
Tris, 0.15 M NaCl, 2 mM MgCl2 and 3 mM bile salt mixture pH 7.5,
whereas acid SMase was determined in 50 mM Tris–maleate buffer
containing 0.15 M NaCl and 3 mM bile salt mixture pH 5.0 (Duan
et al, 1995b).
Other biochemical determinations
Protein content was assayed by a kit obtained from Bio-Rad Co.
(Hercules, CA, USA), using bovine serum albumin as a standard.
A kit obtained from Sigma using p-nitrophenyl phosphate as a
substrate was used to assay alkaline phosphatase.
Statistical analysis
The data were presented as mean ± standard error of mean (s.e.m.)
and the significant differences (P < 0.05) were evaluated using the
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Table 1 Characteristics of endoscopically removed sporadic rectosigmoid
colorectal tubulovillous adenomas from 13 patients
Patient no. Sex Age Dysplasia Size (mm)
1 Female 78 Moderate 10
2 Female 49 Mild 5
3 Female 72 Mild 5
4 Male 82 Severe 25
5 Male 75 Moderate 10
6 Female 80 Moderate 8
7 Male 63 Mild 5
8 Male 72 Moderate 14
9 Male 67 Moderate 6
10 Male 71 Severe 5
11 Female 76 Mild 9
12 Male 82 Severe 20
13 Female 69 Severe 8
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Figure 1 Alkaline, neutral and acid SMase activities (mean ± s.e.m.) in
rectal biopsies from normal mucosa of a control group, from FAP adenomas
and from the surrounding mucosa in the FAP patients. The samples were
homogenized followed by sonication. After centrifugation, the SMase
activities and protein content in the supernatant were determined. *P < 0.05,
**P < 0.01, ***P < 0.001, NS = no significanceMann–Whitney U-test, except for the paired data where Wilcoxon
signed rank test was used.
RESULTS
Changes in SMase activities in FAP-adenomas
We first studied the activities of all three types of SMases in rectal
adenoma tissue and normal surrounding mucosa in 11 FAP
patients who had been operated with an ileorectal anastomosis and
compared them to the activities of a control group with macro- and
microscopically normal rectal mucosa. As shown in Figure 1,
alkaline SMase activity in adenoma tissue was markedly reduced
by 90% compared to controls (P < 0.0001). Neutral and acid
SMase activities were, to a lesser extent, also decreased by 66% (P
= 0.0028) and 54% (P = 0.021) respectively. Similar reductions of
SMase activities were also found in the surrounding normal
mucosa of the FAP patients, by 90% for alkaline SMase (P =
0.0009), by 64% for neutral SMase (P = 0.022) and by 43% for
acid SMase (NS).
Since the data above were obtained from patients who had
undergone ileorectal anastomosis, the possible influence of the
operation on alkaline SMase activity needed to be examined. We
therefore further assayed the enzyme activity in rectal biopsies
from three young FAP patients with intact colon. The results are
shown in Figure 2. Alkaline SMase activities in the rectum of non-
operated patients, both concerning adenoma tissue and the adja-
cent mucosa, did not differ from those in the operated group,
indicating that the operation did not affect the outcome.
Changes in SMase activities in sporadic adenomas
When the SMase activities were determined in sporadic adenoma-
tous tissue from the rectosigmoid region, we found that the activity
of alkaline SMase was reduced by 57% compared to controls (P =
0.014), whereas acid and neutral SMase did not differ signifi-
cantly. The adjacent mucosa did not differ significantly from
controls in any of the SMases (Figure 3). The magnitude of the
decrease of alkaline SMase activity did not correlate with the size
of the adenoma or with the grade of dysplasia.
Changes in alkaline phosphatase activity
For comparison, alkaline phosphatase, which, similarly to alkaline
SMase, is located in the brushborder, was determined. There were
no significant differences of the enzyme activity between the
adenoma tissue and the surrounding mucosa in FAP patients, and
no difference could be found comparing any of the values to
controls. In sporadic adenoma tissue, alkaline phosphatase activity
was reduced by 67% compared to controls (P = 0.0061) and by
43% compared to the surrounding mucosa in the same patients
(P = 0.040) (Figure 4). However, there was no significant correla-
tion between alkaline SMase and alkaline phosphatase activities
(Figure 5).
DISCUSSION
SMase, by catalyzing the hydrolysis of SM, generates multiple
molecules, some of which have been considered as tumour
suppressors due to their antiproliferative effects (Hannun and
Linnardic, 1993). We recently showed that in the tissue of human
colorectal carcinoma alkaline SMase activity was decreased by
234 E Hertervig et al
British Journal of Cancer (1999) 81(2), 232–236 © 1999 Cancer Research Campaign
14
11
8
5
3
2
1
0
A
l
k
a
l
i
n
e
 
S
M
a
s
e
 
a
c
t
i
v
i
t
y
(
n
m
o
l
e
 
h
–
1
 
m
g
–
1
 
p
r
o
t
e
i
n
)
Adenoma tissue
Surrounding mucosa
Controls Ileorectal
anastomosis
Intact colon
Figure 2 Comparison of alkaline SMase activities in rectal biopsies from
FAP patients, with an ileorectal anastomosis to those with an intact colon and
a control group. Biopsies were taken both from adenoma tissue and the
surrounding mucosa
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Figure 3 Alkaline, neutral and acid SMase activities (mean ± s.e.m.) in
sporadic adenomas and the normal surrounding mucosa in the rectosigmoid
colon, compared to a control group. *P < 0.05
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Figure 4 Alkaline phosphatase activities in adenoma tissue and in the
surrounding normal mucosa from patients with FAP adenomas and sporadic
adenomas together with a control group75% as compared with the surrounding mucosa, implying a poten-
tial role of this enzyme in colonic tumorigenesis (Hertervig et al,
1997). In this study, we extended our previous studies by demon-
strating a marked decrease by 90% of alkaline SMase activity in
the colorectal adenomas and in the surrounding mucosa of FAP
patients compared to controls. The reduction of alkaline SMase
activity is specific, not only because of the predominant decrease
as compared to acid and neutral SMase, but also because there was
no change of alkaline phosphatase activity, a brush border enzyme
similar to alkaline SMase. In sporadic adenomas, alkaline phos-
phatase activity was reduced but we found no correlation of the
reduction to changes of alkaline SMase. Although most of the data
from FAP patients were obtained from patients who had under-
gone colectomy and ileorectal anastomosis, the operation is not
attributable to the decrease of alkaline SMase activity, since low
levels of the enzyme activities were similarly found in the non-
operated FAP patients.
An important question is whether a difference in the amounts of
tissue components between normal mucosal and adenoma may
influence the results significantly. This is unlikely for the following
reasons. First, the reduction of alkaline SMAse was seen also in the
normal appearing mucosa of FAP patients and histological features
of randomly taken colonoscopic biopsies from normal appearing
mucosa of FAP patients rarely show any adenomatous epithelial
proliferation (Yang et al, 1998). Secondly, the similar values per mg
protein of another brush border enzyme, alkaline phosphatase
support that the reduction of alkaline SMase is specific. In our view,
tissue heterogeneity could not explain any significant part of the
90% decrease in alkaline SMase in the normal appearing mucosa
from FAP patients as compared with controls. Finally, concerning
the adenomas, it is generally recognized that colonoscopic biopsies
from benign adenomas contain very high proportions of mucosal
cells (approximately 90%) and exhibit little variations in this
respect. Thus, when comparing samples from adenomas and
normal mucosa the mucosal content of brush border enzymes in
adenomas may be somewhat overestimated. In this study the effect
would be to diminish rather than to enhance the difference between
normal mucosa and adenomas.
As opposed to our previous study on non-inherited colorectal
carcinoma, where the reduction of alkaline SMase activity only
occurred in the carcinoma tissue (Hertervig et al, 1997), the
present study on FAP patients demonstrates decreased alkaline
SMase activity in both adenoma tissue and in the surrounding
normal-appearing mucosa. This may indicate that the reduction is
an early phenomenon and may have genetic connections with the
disease. It is well known that FAP is an inherited autosomal domi-
nant disorder and the consequence of a germline mutation of the
adenomatous polyposis coli (APC) gene (Groden et al, 1991;
Kinzler et al, 1991). The APC gene has been proposed as ‘the gate-
keeper gene’ in the colorectal mucosa, and has recently been
suggested to be implicated in cell signal transduction affecting
processes like cell growth inhibition (Baeg et al, 1995), apoptosis
(Browne et al, 1994) and migration (Wong et al, 1996). Studies in
humans with FAP, as well as in mice with analogous mutations,
have suggested that the rate-limiting step in the tumour initiation is
a somatic mutation of the wild-type APC allele inherited from the
unaffected parent (Icii et al, 1992; Luongo et al, 1994). APC muta-
tions have also been found in humans in the earliest neoplastic
lesions, the dysplastic aberrant crypt foci (Jen et al, 1994). The
APC protein interacts with at least six proteins, among them b-
catenin (Su, 1994). Just recently b-catenin has been shown to func-
tion as a transcriptional activator when complexed with members
of the Tcf family of DNA binding proteins and wild-type APC has
the ability to suppress signalling by the b-catenin-Tcf complex
(Korinek et al, 1997). Furthermore, mutant APC genes are defec-
tive in their ability to down-regulate b-catenin-mediated transcrip-
tional activity (Morin et al, 1997). Missing at present is the
knowledge of which genes are activated by the b-catenin-Tcf
complex. SMase is a key enzyme to trigger a signal transduction
pathway leading to inhibition of cell proliferation and to apoptosis.
Thus, in view of the present data and our previous work on
colorectal carcinoma (Hertervig et al, 1997), it is tempting to spec-
ulate about a possible connection between the APC protein and the
regulation of alkaline SMase expression.
During the last 5 years, the possible link between hydrolysis of
SM and colonic tumorigenesis has become a focus for investiga-
tion. It has been shown that supplement of SM in the diet to normal
mice significantly reduced the number of aberrant crypt foci in the
colon and inhibited the development of colon carcinoma induced
by chemical carcinogens (Dillehay et al, 1994; Schmelz et al,
1996). In agreement with this, human colonic carcinomas as well
as colonic mucosa of rats treated with chemical dimethylhy-
drazine, show an accumulation of SM (Dudeja et al, 1986;
Merchant et al, 1995), which may well be the result of a reduced
SMase activity as shown in our previous work (Hertervig et al,
1997). In addition, ursodeoxycholate, a bile salt that has been
shown to inhibit experimental colon cancer development (Earnest
et al, 1994) has recently been found to increase alkaline SMase
activity in rats (Duan et al, 1998).
In summary, this study shows that a very low level of alkaline
SMase is a feature of both adenoma tissue and the macroscopically
normal appearing mucosa in FAP patients. and thus it may repre-
sent a marker of increased proliferative potential in the mucosa, or
even further, be an important pathogenic mechanism behind the
unrestrained cell proliferation seen in the mucosa of FAP patients.
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